dueranconsultancy
A Subsequent New Drug License (SNDL) is a regulatory approval granted for modifications or variations in an existing drug, such as a new dosage form, strength, or route of administration. It ensures safety, efficacy, and quality standards while allowing for advancements and diversification within pharmaceutical offerings.
Address
Dueran Consultant Private Limited, RZ 20E/ A-3, Ra
New Delhi, NV 110077
Phone
09899018826